Hysteroscopy in one hundred cases of postmenopausal uterine bleeding, in the detection of uterine cancer and atypical endometrial hyperplasia

Pratibha Devabhaktuni, Padmaja Allani, Suneetha Komatlapalli, Rekha Rani Ksheerasagara


Background: Evaluation was done in 100 women presenting with postmenopausal bleeding, (PMB), to discuss the utility of hysteroscopy combined guided endometrial curettage in the diagnosis of uterine cancer and endometrial hyperplasia, and, treat benign lesions, like polyps, synechiae at the same sitting. At MGMH during the years, 2002 to 2006, there were 57 women, and at care, 40 women with PMB during 2011 to 2013, and three in a nursing home, Hyderabad, were investigated.

Methods: Evaluation was done in 100 women presenting with PMB by hysteroscopy and curettage to diagnose the cause of PMB and benign lesions like polyps, synechiae were managed by operative hysteroscopy. Bettocchi 5 mm hysteroscope, monopolar instruments and glycine was used for excision of polyps.

Results: In one hundred women with PMB, 19% had cancer. Endometrial adenocarcinoma in 14, endocervical carcinoma in 2, uterine carcinosarcoma in 3 cases. All 3 cases of uterine carcinosarcoma on hysteroscopy were large polyps measuring 5×5-6 cm size. Atypical hyperplasia endometrium in 7% and simple hyperplasia in 17%, was reported on histopathology, in cases with hyperplastic endometrium on hysteroscopy. Benign polyps in 41% were managed at the same sitting by operative hysteroscopy.

Conclusions: Women with postmenopausal bleeding must have USG, trans vaginal sonography (TVS), endometrial thickness (ET) measurement, preferably endometrial echo complex (EEC). In women with PMB, the risk of uterine cancer would be 19%, i.e., 1 out of 5 women. Atypical hyperplasia in 7%. Hysteroscopy guided curettage, with histopathology, is the gold standard protocol in cases of PMB.


Endometrial cancer, Endometrial curettage, Endometrial hyperplasia, Hysteroscopy, Post-menopausal bleeding, Uterine carcino-sarcoma

Full Text:



Research on the menopause in the 1990s. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1996;866:1-107.

Timmermans A, Opmeer BC, Khan KS. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynecol. 2010;116(1):160-7.

Clark T, Barton P, Coomarasamy A, Gupta J, Khan K. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. BJOG. 2006;113:502-10.

Gordon SJ, Westgate J. The incidence and management of failed Pipelle sampling in a general outpatient clinic. Aust N Z J Obstet Gynaecol. 1999;39(1):115-8.

Nagele F, O’Connor H, Baskett TF, Davies A, Mohammed H, Magos AL. Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding. Fertil Steril. 1996;65(6):1145-50.

Giusa-Chiferi MG, Gonçalves WJ, Baracat EC, de Albuquerque Neto LC, Bortoletto CC, de Lima GR. Transvaginal ultrasound, uterine biopsy and hysteroscopy for post-menopausal bleeding. Int J Gynaecol Obstet. 1996;55(1):39-44.

Jansen FW, Vredevoogd CB, van Ulzen K, Hermans J, Trimbos JB, Trimbos- Kemper TC. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. 2000;96:266e70.

Lee YL, Bai YS, Yin CS. Vaginoscopic hysteroscopy in management for women with post-menopausal vaginal bleeding. Taiwan J Obstet Gynecol. 2019;58:497e500.

Cicinelli E, Didonna T, Ambrosi G, Schonauer LM, Fiore TG, Matteo MG. Topical anaesthesia for diagnostic hysteroscopy and endometrial biopsy in postmenopausal women: a randomised placebo-controlled double-blind study. Br J Obstetr Gynaecol March. 1997;104:316e9.

Tripodi A, De Salvo C, Ermio C, Manuzio D, Romeo G, Vadalà P. Importance of office hysteroscopy screening to diagnose endometrial carcinoma in menopausal women. Eur J Gynaecol Oncol Int J. 2011;3:303-7.

Chandavarkar U, Kuperman J, Muderspach L. Postmenopausal endometrial cancer: evaluating the role of endometrial echo complex. Gynecol Oncol. 2011;120:S11.

Wang J, Wieslander C, Hansen G, Cass I, Vasilev S, Holschneider CH. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol Oncol. 2006;101(1):120-5.

Van Doorn LC, Dijkhuizen FP, Kruitwagen RF, Heintz AP, Kooi GS. Accuracy of trans vaginal ultrasonography in diabetic or obese women with postmenopausal bleeding. Obstet Gynaecol. 2004;104:571-8.

Martinez Rubio M, Alcazar J. Ultrasonographic and pathological endometrial findings in asymptomatic postmenopausal women taking antihypertensive drugs. Maturitas. 2003;46:27-32.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice: Committee Opinion No. 601: Tamoxifen and uterine cancer. Obstet Gynecol. 2014;123:1394.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice: Tamoxifen and endometrial Cancer. Committee opinion 232. ACOG; Washington, DC.; 2000.

Ettinger B, Li DK, Klein R. Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules. Fertil Steril. 1998;69(5):865-9.

Scottish intercollegiate guidelines network. Investigation of Post-9. Menopausal bleeding section 5: interpretation of transvaginal ultrasound (TVUS). Edinburgh: SIGN; 2002.

Smith-Bindman R, Weiss E, Feldstein V. How thick is too thick? When 10. endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol. 2004;24:558.

Devabhaktuni P, Suneeta K, Kancharla K. Role of hysteroscopy and endometrial curettage in postmenopausal women with and without postmenopausal bleeding. Gynecol Obstet Open Acc. 2018:OBOA-125.

Trimble CL, Method M, Leitao M. Management of endometrial precancers. Obstet Gynecol. 2012;120:1160.

Byun JM, Jeong DH, Kim YN, Cho EB, Cha JE, Sung MS, Lee KB, Kim KT. Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge. Obstet Gynecol Sci. 2015;58(6):468-74.

Mencaglia L. Hysteroscopy and adenocarcinoma. Obstet Gynecol Clin North Am. 1995;22(3):573-9.

Jillani K, Khero RB, Maqsood S, Siddiqui MA. Prevalence of malignant disorders in 50 cases of postmenopausal bleeding. J Pak Med Asso. 2010;60(7):540.

Tandulwadkar S, Deshmukh P, Ln P. Hysteroscopy in post24. menopausal women. J Gynecol Endosc Surg. 2009;1:89-93.

Devi YS, Swapna KT, Naidu TK. Conservative surgical alternatives to hysterectomy, Chapter in Obstet Gynecol Update; 2011:249-295.

Devi YS, Swapna KT. Diagnostic and operative hysteroscopy in the management of postmenopausal bleeding. J Obst Gyn India. 2001;51(2):115-9.

Singh P, Dwivedi P, Mendiratta S. Correlation of endometrial thickness with the histopathological pattern of endometrium in postmenopausal bleeding. J Obstet Gynaecol India. 2016;66(1):42-6.

Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial Cancer. Lancet. 2005;366:491-505.

Gerber B, Krause A, Müller H, Reimer T, Külz T. Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding. Eur J Cancer. 2001;37:64-71.